Anixa Biosciences Ownership | Who Owns Anixa Biosciences?


OverviewForecastFinancialsChart

Anixa Biosciences Ownership Summary


Anixa Biosciences is owned by 15.94% institutional investors, 5.50% insiders, and 78.57% retail investors. Vanguard group is the largest institutional shareholder, holding 4.50% of ANIX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.88% of its assets in Anixa Biosciences shares.

ANIX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAnixa Biosciences15.94%5.50%78.57%
SectorHealthcare Stocks 50.44%12.38%37.18%
IndustryBiotech Stocks 48.97%12.07%38.96%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group1.46M4.50%$4.55M
Vanguard capital management1.33M3.96%$3.72M
Ubs group585.43K1.74%$1.64M
Laird norton trust company578.73K1.72%$1.62M
D.a. davidson539.27K1.61%$1.51M
Geode capital management359.19K1.07%$1.01M
Marshall wace, llp328.33K0.98%$919.33K
Bank of america corp /de/216.91K0.68%$479.38K
Blackrock funding, inc. /de199.75K0.59%$559.31K
Vanguard fiduciary trust192.36K0.57%$538.60K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Prosperity wealth management41.80K0.05%$137.94K
Laird norton trust company578.73K0.03%$1.62M
Gsa capital partners llp117.47K0.02%$329.00K
Tyler-stone wealth management42.02K0.02%$97.48K
Lifepro asset management10.76K0.02%$23.78K
Westside investment management43.00K0.02%$120.40K
Concorde asset management12.00K0.01%$37.44K
D.a. davidson539.27K0.01%$1.51M
Gemmer asset management35.00K0.01%$98.00K
Axq capital, lp14.63K0.00%$40.97K

Top Buyers

HolderShares% AssetsChange
Marshall wace, llp328.33K0.00%155.15K
Bank of america corp /de/216.91K-100.00K
Vanguard group1.46M0.00%37.23K
Ubs group585.43K0.00%33.79K
Modern wealth management32.00K0.00%32.00K

Top Sellers

HolderShares% AssetsChange
Mission wealth management, lp---206.90K
Long focus capital management---147.36K
683 capital management---113.64K
Susquehanna group, llp---99.47K
Exoduspoint capital management, lp---93.93K

New Positions

HolderShares% AssetsChangeValue
Modern wealth management32.00K0.00%32.00K$89.60K
Axq capital, lp14.63K0.00%14.63K$40.97K
Group one trading13.53K0.00%13.53K$37.89M
Sixth street partners management company12.80K-12.80K$35.83K
Integrated wealth concepts10.88K0.00%10.88K$30.48K

Sold Out

HolderChange
Citigroup-1.00
Barrett & company-80.00
Fmr-250.00
Hurley capital-314.00
Advisory services network-400.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026653.17%5,354,7054.86%156.90%297.41%8-20.00%
Mar 31, 202638-46.48%3,493,076-38.24%103.46%16-46.67%3-78.57%
Dec 31, 202548-28.36%4,245,881-21.80%134.68%18-30.77%8-
Sep 30, 202563-5.97%5,412,5281.19%166.04%249.09%7-46.15%
Jun 30, 20256611.86%5,307,306-5.33%165.44%2215.79%1385.71%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF927.84K2.88%-
Vanguard Morn Total Stk Mkt Idx Investor936.93K2.75%-
Vanguard Total Stock Mkt Idx Inv936.93K2.75%-
Vanguard Institutional Extnd Mkt Idx Tr353.88K1.04%-
Fidelity Extended Market Index163.71K0.48%-3.55K
iShares Micro-Cap ETF106.08K0.31%-1.41K
Extended Equity Market Fund E83.65K0.25%-
Extended Equity Market Fund B83.65K0.25%-
Blackrock Extended Mkt Fund CF83.65K0.25%-
BlackRock Extended Equity Market K72.90K0.23%-31.00

Recent Insider Transactions


DateNameRoleActivityValue
Jul 31, 2026KUMAR AMIT Chief Executive OfficerBuy$17.35K
Jul 27, 2026KUMAR AMIT Chief Executive OfficerBuy$17.20K
Jul 27, 2026KUMAR AMIT Chief Executive OfficerBuy$10.74K
Jul 24, 2026KUMAR AMIT Chief Executive OfficerBuy$11.19K
Jul 20, 2026KUMAR AMIT Chief Executive OfficerBuy$17.30K

Insider Transactions Trends


DateBuySell
2026 Q37-
2026 Q22-
2026 Q11-
2025 Q4--
2025 Q35-

ANIX Ownership FAQ


Who Owns Anixa Biosciences?

Anixa Biosciences shareholders are primarily institutional investors at 15.94%, followed by 5.50% insiders and 78.56% retail investors. The average institutional ownership in Anixa Biosciences's industry, Biotech Stocks , is 48.97%, which Anixa Biosciences falls below.

Who owns the most shares of Anixa Biosciences?

Anixa Biosciences’s largest shareholders are Vanguard group (1.46M shares, 4.50%), Vanguard capital management (1.33M shares, 3.96%), and Ubs group (585.43K shares, 1.74%). Together, they hold 10.20% of Anixa Biosciences’s total shares outstanding.

Does Blackrock own Anixa Biosciences?

BlackRock is not among the top 10 institutional shareholders of Anixa Biosciences.

Who is Anixa Biosciences’s biggest shareholder by percentage of total assets invested?

Prosperity wealth management is Anixa Biosciences’s biggest shareholder by percentage of total assets invested, with 0.05% of its assets in 41.8K Anixa Biosciences shares, valued at 137.94K$.

Who is the top mutual fund holder of Anixa Biosciences shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Anixa Biosciences shares, with 2.88% of its total shares outstanding invested in 927.84K Anixa Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools